M2 and M3 muscarinic acetylcholine receptors — Drug Target

All drugs that target M2 and M3 muscarinic acetylcholine receptors — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Muscarinic receptor antagonist

Marketed (1)

• Detrol LA · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Muscarinic receptor antagonist · Urology
  Detrol LA is a muscarinic receptor antagonist that blocks acetylcholine signaling in the bladder to reduce involuntary muscle contractions and urinary urgency.